Celtic Medical

Celtic aims to dramatically improve early-stage colorectal cancer screening through a simple, non-invasive test, to ensure that far fewer people suffer from this type of cancer and many more can be cured in the future. The benefits of this test will be to improve early diagnosis, increase diagnostic coverage for patients who do not have a faecal immunochemical test (FIT), and reduce the pressure on the healthcare system due to the excessive number of colonoscopies.